Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity.

Source:http://linkedlifedata.com/resource/pubmed/id/17503041

Download in:

View as

General Info

PMID
17503041